P215 - Risk assessment in humans using physiologically based pharmacokinetic model of diisobutyl phthalate and its major metabolite, monoisobutyl phthalate: Development and evaluation of model
2020 ◽
Vol 94
(7)
◽
pp. 2377-2400
◽
2015 ◽
Vol 73
(2)
◽
pp. 530-543
◽
2017 ◽
Vol 92
(3)
◽
pp. 1113-1131
◽
1995 ◽
Vol 46
(2)
◽
pp. 155-163
◽